European Heart Journal Advance Access published online on March 16, 2006
European Heart Journal, doi:10.1093/eurheartj/ehi793
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cardiovascular Center, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium
* To whom correspondence should be addressed. A task force has been established by the European Society of Cardiology to investigate the role of progenitor/stem cell therapy in the treatment of cardiovascular disease. This article is the consensus of this group, of what clinical studies are needed in this field, and the challenges to be addressed in the translation of progenitor/stem cell biology to repair of the heart.
Received January 16, 2006
Accepted January 26, 2006
ESC Report
The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart
Jozef Bartunek 1,
Stephanie Dimmeler 2,
Helmut Drexler 3,
Francisco Fernandez-Aviles 4,
Manuel Galinanes 5,
Stefan Janssens 6,
John Martin 7 *,
Anthony Mathur 8,
Phillipe Menasche 9,
Sylvia Priori 10,
Bodo Strauer 11,
Michal Tendera 12,
William Wijns 13,
and
Andreas Zeiher 2
2 Molecular Cardiology, Department of Medicine III, J.W. Goethe University, Frankfurt, Germany
3 Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
4 Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico-Universitario, Valladolid, Spain
5 Cardiac Surgery Unit, Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK
6 Department of Cardiology, University Hospital, Gasthuisberg, Leuven, Belgium
7 Centre for Cardiovascular Biology & Medicine, BHF Laboratories at University College London, 5 University Street, London WC1E 6JJ
8 Department of Cardiology, London Chest Hospital, Bonner Road, London, UK
9 Assistance Publique-Hopitaux de Paris, Hopital Europeen Georges Pompidou, Department of Cardiovascular Surgery, Universite Paris-Descartes, Faculte de Medecine, INSERM U 633, France
10 Department of Cardiology, University of Pavia, Italy
11 Heinrich-Heine-Universitat Dusseldorf, Klinik fur Kardiologie, Pneumologie und Angiologie, Moorenstr. 5 40225 Dusseldorf, Germany
12 3rd Division of Cardiology, School of Medicine, Katowice, Poland
13 Cardiovascular Centre Aalst, OLV Clinic, Aalst, Belgium
John Martin, E-mail: john.martin{at}ucl.ac.uk
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. J. Gersh, R. D. Simari, A. Behfar, C. M. Terzic, and A. Terzic Cardiac Cell Repair Therapy: A Clinical Perspective Mayo Clin. Proc., October 1, 2009; 84(10): 876 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Kyrtatos, P. Lehtolainen, M. Junemann-Ramirez, A. Garcia-Prieto, A. N. Price, J. F. Martin, D. G. Gadian, Q. A. Pankhurst, and M. F. Lythgoe Magnetic Tagging Increases Delivery of Circulating Progenitors in Vascular Injury J. Am. Coll. Cardiol. Intv., August 1, 2009; 2(8): 794 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L Kao, W. Browder, and C. Li Cellular Cardiomyoplasty: What Have We Learned? Asian Cardiovasc Thorac Ann, January 1, 2009; 17(1): 89 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Watts Regeneration games BMJ, December 3, 2008; 337(dec03_1): a1321 - a1321. [Full Text]
|
|
|
|
 |
|
 M. Korf-Klingebiel, T. Kempf, T. Sauer, E. Brinkmann, P. Fischer, G. P. Meyer, A. Ganser, H. Drexler, and K. C. Wollert Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction Eur. Heart J., December 1, 2008; 29(23): 2851 - 2858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L M A Beeres, D. E Atsma, J. van Ramshorst, M. J Schalij, and J. J Bax Cell therapy for ischaemic heart disease Heart, September 1, 2008; 94(9): 1214 - 1226. [Full Text] [PDF]
|
|
|
|
|
|
E. Martin-Rendon, S. J. Brunskill, C. J. Hyde, S. J. Stanworth, A. Mathur, and S. M. Watt Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review Eur. Heart J., August 1, 2008; 29(15): 1807 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kaczmarczyk Is the clinical use of adult stem cells a realistic possibility for myocardial regeneration? Bioscience Horizons, March 1, 2008; 1(1): 67 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abdel-Latif, R. Bolli, I. M. Tleyjeh, V. M. Montori, E. C. Perin, C. A. Hornung, E. K. Zuba-Surma, M. Al-Mallah, and B. Dawn Adult Bone Marrow-Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis Arch Intern Med, May 28, 2007; 167(10): 989 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Behfar, C. Perez-Terzic, R. S. Faustino, D. K. Arrell, D. M. Hodgson, S. Yamada, M. Puceat, N. Niederlander, A. E Alekseev, L. V. Zingman, et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair J. Exp. Med., February 19, 2007; 204(2): 405 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Leone and F. Crea Stem cells in acute myocardial infarction: the good, the bad, and the ugly Eur. Heart J., December 2, 2006; 27(24): 2911 - 2913. [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. van Laake, R. Hassink, P. A. Doevendans, and C. Mummery Heart repair and stem cells J. Physiol., December 1, 2006; 577(2): 467 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rosenzweig Cardiac cell therapy--mixed results from mixed cells. N. Engl. J. Med., September 21, 2006; 355(12): 1274 - 1277. [Full Text] [PDF]
|
|